{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:02:55Z","timestamp":1789585375816,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12928-026-01314-x","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:01:04Z","timestamp":1782230464000},"page":"883-888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Residual inflammatory risk after percutaneous coronary intervention: current insights and future perspectives"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0579-6196","authenticated-orcid":false,"given":"Tomoya","family":"Hara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Sata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"1314_CR1","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1161\/circulationaha.123.065770","volume":"148","author":"FM Zimmermann","year":"2023","unstructured":"Zimmermann FM, Ding VY, Pijls NHJ, Piroth Z, van Straten AHM, Szekely L, et al. Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial. Circulation. 2023;148:950\u20138. https:\/\/doi.org\/10.1161\/circulationaha.123.065770.","journal-title":"Circulation"},{"key":"1314_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12928-023-00921-2","volume":"38","author":"T Muramatsu","year":"2023","unstructured":"Muramatsu T, Kozuma K, Tanabe K, Morino Y, Ako J, Nakamura S, et al. Clinical expert consensus document on drug-coated balloon for coronary artery disease from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther. 2023;38:166\u201376. https:\/\/doi.org\/10.1007\/s12928-023-00921-2.","journal-title":"Cardiovasc Interv Ther"},{"key":"1314_CR3","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1056\/NEJMoa2216607","volume":"388","author":"JM Lee","year":"2023","unstructured":"Lee JM, Choi KH, Song YB, Lee JY, Lee SJ, Lee SY, et al. Intravascular Imaging-Guided or Angiography-Guided Complex PCI. N Engl J Med. 2023;388:1668\u201379. https:\/\/doi.org\/10.1056\/NEJMoa2216607.","journal-title":"N Engl J Med"},{"key":"1314_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12928-022-00874-y","volume":"38","author":"S Yamada","year":"2023","unstructured":"Yamada S, Adachi T, Ashikawa H, Funaki K, Kohsaka S, Ikari Y, et al. National survey on the secondary preventive measures for coronary artery disease among interventional cardiologists: a report from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther. 2023;38:49\u201354. https:\/\/doi.org\/10.1007\/s12928-022-00874-y.","journal-title":"Cardiovasc Interv Ther"},{"key":"1314_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1253\/circrep.CR-24-0096","volume":"6","author":"K Baba","year":"2024","unstructured":"Baba K, Nishihira K, Shibata Y. Effectiveness of Intravascular Lithotripsy on an Underexpanded Stent Due to Severe Calcification. Circ Rep. 2024;6:471\u20132. https:\/\/doi.org\/10.1253\/circrep.CR-24-0096.","journal-title":"Circ Rep"},{"key":"1314_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/circulationaha.123.066213","volume":"149","author":"PM Ridker","year":"2024","unstructured":"Ridker PM, Lei L, Louie MJ, Haddad T, Nicholls SJ, Lincoff AM, et al. Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance. Circulation. 2024;149:28\u201335. https:\/\/doi.org\/10.1161\/circulationaha.123.066213.","journal-title":"Circulation"},{"key":"1314_CR7","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1253\/circj.CJ-23-0031","volume":"87","author":"S Kimura","year":"2023","unstructured":"Kimura S, Isshiki A, Shimizu M, Fujii H, Suzuki M. Clinical Significance of Coronary Healed Plaques in Stable Angina Pectoris Patients Undergoing Percutaneous Coronary Intervention. Circ J. 2023;87:1643\u201353. https:\/\/doi.org\/10.1253\/circj.CJ-23-0031.","journal-title":"Circ J"},{"key":"1314_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature. 2021;592:524\u201333. https:\/\/doi.org\/10.1038\/s41586-021-03392-8.","journal-title":"Nature"},{"key":"1314_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","volume":"20","author":"O Soehnlein","year":"2021","unstructured":"Soehnlein O, Libby P. Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nat Rev Drug Discov. 2021;20:589\u2013610. https:\/\/doi.org\/10.1038\/s41573-021-00198-1.","journal-title":"Nat Rev Drug Discov"},{"key":"1314_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/circulationaha.113.001790","volume":"129","author":"F Otsuka","year":"2014","unstructured":"Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation. 2014;129:211\u201323. https:\/\/doi.org\/10.1161\/circulationaha.113.001790.","journal-title":"Circulation"},{"key":"1314_CR11","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa2307770","volume":"389","author":"NR Holm","year":"2023","unstructured":"Holm NR, Andreasen LD, Neghabat O, Laanmets P, Kumsars I, Bennett J, et al. OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions. N Engl J Med. 2023;389:1477\u201387. https:\/\/doi.org\/10.1056\/NEJMoa2307770.","journal-title":"N Engl J Med"},{"key":"1314_CR12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377:1119\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1707914.","journal-title":"N Engl J Med"},{"key":"1314_CR13","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, et al. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020;383:1838\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2021372.","journal-title":"N Engl J Med"},{"key":"1314_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12928-024-01080-8","volume":"40","author":"K Fujii","year":"2025","unstructured":"Fujii K, Kubo T, Otake H, Nakazawa G, Sonoda S, Hibi K, et al. Expert consensus statement for quantitative measurement and morphologic assessment of optical coherence tomography: update 2025. Cardiovasc Interv Ther. 2025;40:226\u201333. https:\/\/doi.org\/10.1007\/s12928-024-01080-8.","journal-title":"Cardiovasc Interv Ther"},{"key":"1314_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1253\/circrep.CR-24-0012","volume":"6","author":"T Yamano","year":"2024","unstructured":"Yamano T, Thammakumpee K, Nabkasorn C, Ritngam A, Krungkraipetch N, Kaewwilai L, et al. Impact of Climate on the Incidence of Acute Coronary Syndrome - Differences Between Japan and Thailand. Circ Rep. 2024;6:134\u201341. https:\/\/doi.org\/10.1253\/circrep.CR-24-0012.","journal-title":"Circ Rep"},{"key":"1314_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1253\/circrep.CR-24-0044","volume":"6","author":"T Sugiyama","year":"2024","unstructured":"Sugiyama T, Kanaji Y, Hoshino M, Hada M, Hanyu Y, Nagamine T, et al. Prognostic Value of Integrated Assessment of Cardiac Magnetic Resonance-Derived Global Coronary Flow Reserve and Cardiopulmonary Exercise Testing-Derived Peak Oxygen Consumption in Patients With Acute Myocardial Infarction. Circ Rep. 2024;6:255\u201362. https:\/\/doi.org\/10.1253\/circrep.CR-24-0044.","journal-title":"Circ Rep"},{"key":"1314_CR17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1253\/circrep.CR-25-0219","volume":"8","author":"M Koide","year":"2026","unstructured":"Koide M, Zen K, Seki T, Fukui K, Takamatsu K, Shiraishi J, et al. Impact of Plaque Morphology on Drug-Coated Balloon Treatment Outcomes for Coronary Calcified Lesions: An Optical Coherence Tomography Analysis. Circ Rep. 2026;8:544\u201353. https:\/\/doi.org\/10.1253\/circrep.CR-25-0219.","journal-title":"Circ Rep"},{"key":"1314_CR18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12928-025-01130-9","volume":"40","author":"M Nakamura","year":"2025","unstructured":"Nakamura M, Kuriyama N, Tanaka Y, Yamazaki S, Kawasaki T, Muramatsu T, et al. Dual-Prep registry: atherectomy devices and intravascUlAr lithotripsy for the PREParation of heavily calcified coronary lesions registry. Cardiovasc Interv Ther. 2025;40:553\u201364. https:\/\/doi.org\/10.1007\/s12928-025-01130-9.","journal-title":"Cardiovasc Interv Ther"},{"key":"1314_CR19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1253\/circrep.CR-25-0133","volume":"7","author":"Y Otaki","year":"2025","unstructured":"Otaki Y, Kinoshita D, Mito T, Goto J, Shikama T, Kato S, et al. Associations of Thrombotic and Bleeding Risks With Plaque Morphology. Circ Rep. 2025;7:939\u201347. https:\/\/doi.org\/10.1253\/circrep.CR-25-0133.","journal-title":"Circ Rep"},{"key":"1314_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1253\/circrep.CR-24-0003","volume":"6","author":"N Kobayashi","year":"2024","unstructured":"Kobayashi N, Shibata Y, Kurihara O, Todoroki T, Tsutsumi M, Shirakabe A, et al. Clinical Background and Coronary Artery Lesions Characteristics in Japanese Patients With Acute Coronary Syndrome Suffering Major Bleeding. Circ Rep. 2024;6:64\u201373. https:\/\/doi.org\/10.1253\/circrep.CR-24-0003.","journal-title":"Circ Rep"},{"key":"1314_CR21","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s12928-025-01137-2","volume":"40","author":"K Wakabayashi","year":"2025","unstructured":"Wakabayashi K, Yonetsu T, Mizukami T, Yamamoto MH, Yasuhara S, Shishido K, et al. Feasibility of optical coherence tomography-guided primary percutaneous coronary intervention for STEMI: all-comer ATLAS-OCT trial. Cardiovasc Interv Ther. 2025;40:576\u201387. https:\/\/doi.org\/10.1007\/s12928-025-01137-2.","journal-title":"Cardiovasc Interv Ther"},{"key":"1314_CR22","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019;381:2497\u2013505. https:\/\/doi.org\/10.1056\/NEJMoa1912388.","journal-title":"N Engl J Med"},{"key":"1314_CR23","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/s0140-6736(21)00520-1","volume":"397","author":"PM Ridker","year":"2021","unstructured":"Ridker PM, Devalaraja M, Baeres FMM, Engelmann MDM, Hovingh GK, Ivkovic M, et al. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet. 2021;397:2060\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(21)00520-1.","journal-title":"Lancet"},{"key":"1314_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jjcc.2023.05.006","volume":"82","author":"Y Wada","year":"2023","unstructured":"Wada Y, Jensen C, Meyer ASP, Zonoozi AAM, Honda H. Efficacy and safety of interleukin-6 inhibition with ziltivekimab in patients at high risk of atherosclerotic events in Japan (RESCUE-2): A randomized, double-blind, placebo-controlled, phase 2 trial. J Cardiol. 2023;82:279\u201385. https:\/\/doi.org\/10.1016\/j.jjcc.2023.05.006.","journal-title":"J Cardiol"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-026-01314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-026-01314-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-026-01314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:14:45Z","timestamp":1789582485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-026-01314-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1007\/s12928-026-01314-x","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that this study was conducted and described in the absence of any commercial or financial relationships that could be considered a potential conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}